par Abdel Azim, Hatem Hamdy ;de Azambuja, Evandro ;Agbor-Tarh, Dominique;Bradbury, Ian
Référence Journal of clinical oncology, 32, 30, page (3459)
Publication Publié, 2014-10
Référence Journal of clinical oncology, 32, 30, page (3459)
Publication Publié, 2014-10
Lettre à l'éditeur
Titre: |
|
Auteur: | Abdel Azim, Hatem Hamdy; de Azambuja, Evandro; Agbor-Tarh, Dominique; Bradbury, Ian |
Informations sur la publication: | Journal of clinical oncology, 32, 30, page (3459) |
Statut de publication: | Publié, 2014-10 |
Sujet CREF: | Généralités |
MeSH keywords: | Antibodies, Monoclonal, Humanized -- adverse effects |
Antineoplastic Agents -- adverse effects | |
Breast Neoplasms -- drug therapy | |
Diarrhea -- chemically induced | |
Drug Eruptions -- etiology | |
Drug-Induced Liver Injury -- etiology | |
Female | |
Humans | |
Neoadjuvant Therapy -- methods | |
Quinazolines -- adverse effects | |
Note générale: | SCOPUS: le.j |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2014.57.0945 | |
info:pii/JCO.2014.57.0945 | |
info:scp/84908459727 | |
info:pmid/25225439 |